2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)-
- CAS No.
- 2313528-04-8
- Chemical Name:
- 2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)-
- Synonyms
- hnRNPK-IN-1;hnRNPK IN 1,hnRNPKIN1;2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)-
- CBNumber:
- CB58843929
- Molecular Formula:
- C23H21N3O5
- Molecular Weight:
- 419.43
- MDL Number:
- MFCD34179487
- MOL File:
- 2313528-04-8.mol
Boiling point | 673.6±55.0 °C(Predicted) |
---|---|
Density | 1.325±0.06 g/cm3(Predicted) |
storage temp. | Store at -20°C |
solubility | DMSO : 5 mg/mL (11.92 mM; ultrasonic and warming and heat to 80°C) |
pka | 3.81±0.61(Predicted) |
form | Solid |
color | Brown to orange |
2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)- Chemical Properties,Uses,Production
Biological Activity
hnRNPK-IN-1 is a heterogeneous nuclear ribonucleoprotein K (hnRNPK) binding ligand with Kd values of 4.6 μM and 2.6 μM measured with SPR and MST, respectively. hnRNPK-IN-1 inhibits c-myc transcription by disrupting the binding of hnRNPK and c-myc promoter. hnRNPK-IN-1 induces Hela cells apoptosis and has strongly anti-tumor activities[1]. hnRNPK-IN-1 (Compound 25; 1.25-5 μM; 24 hours) treatment induces Hela cells apoptosis could be due to its repression of cmyc transcription[1].hnRNPK-IN-1 (1.25-5 μM; 48 hours) treatment down-regulates c-myc gene transcription and expression in Hela cells in a dose-dependent manner[1].hnRNPK-IN-1 shows a selective anti-proliferative effect on human cancer cell lines (Siha, A549, Hela, U2OS, A375, HuH7 and HEK293 cells) with IC50 values ranged from 1.36 to 3.59 μM[1].hnRNPK-IN-1 could selectively bind to hnRNP K without significant interaction with c-myc promoter DNA. The binding of hnRNPK-IN-1 to hnRNP K could disrupt the interaction between hnRNP K and c-myc promoter DNA in vitro and in cells[1]. hnRNPK-IN-1 (Compound 25; 6.7-20 mg/kg; i.p.; once a day; for three weeks) exhibits good tumor growth inhibition in a Hela xenograft tumor model[1].
References
[1]. Bing Shu, et al. Syntheses and evaluation of new Quinoline derivatives for inhibition of hnRNP K in regulating oncogene c-myc transcription. Bioorg Chem. 2019 Apr;85:1-17.
2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)- Preparation Products And Raw materials
Raw materials
Preparation Products
2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)- Suppliers
Supplier | Tel | Country | ProdList | Advantage | |
---|---|---|---|---|---|
Aladdin Scientific | +1-+1(833)-552-7181 | sales@aladdinsci.com | United States | 52924 | 58 |
TargetMol Chemicals Inc. | +8613564774135 | zijue.cai@tsbiochem.com | United States | 19881 | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 021-65675885 18964387627 | customer_service@efebio.com | China | 11974 | 58 |
TargetMol Chemicals Inc. | 15002134094 | marketing@targetmol.cn | China | 19699 | 58 |
Supplier | Advantage |
---|---|
Aladdin Scientific | 58 |
TargetMol Chemicals Inc. | 58 |
Shanghai Yifei Biotechnology Co. , Ltd. | 58 |
TargetMol Chemicals Inc. | 58 |
View Lastest Price from 2-Propen-1-one, 1-(4-methoxyphenyl)-3-[4-(4-morpholinyl)-6-nitro-2-quinolinyl]-, (2E)- manufacturers
Image | Update time | Product | Price | Min. Order | Purity | Supply Ability | Manufacturer | |
---|---|---|---|---|---|---|---|---|
![]() |
2024-10-28 | hnRNPK-IN-1
2313528-04-8
|
US $2500.00-1980.00 / mg | 10g | TargetMol Chemicals Inc. |
-
- hnRNPK-IN-1
2313528-04-8
- US $2500.00-1980.00 / mg
- TargetMol Chemicals Inc.